Search Results
Results found for "neuroimmune signaling"
Posts (401)
- Building Backwards: Why Top-Down Models Could Revolutionize Pain Research
He also integrates concepts like sex differences , epigenetic inheritance , and neuroimmune crosstalk _______ Keyword Cloud: GPCR podcast , pain modeling , GPCR online course , translational research , neuroimmune signaling .
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Biased signalling and allosteric machines: new vistas and challenges for drug discovery. Allosteric modulation of G protein-coupled receptor signaling. Biased Receptor Signaling in Drug Discovery. Pharmacol Rev. 2019;71(2):267-315. 33. Science signaling. 2024;17(841):eadi4747. 37. Science signaling. 2024;17(843):eabq7038. 38.
- How GPCR Spatial Signaling Sparked a Scientific Journey
It’s about chasing a signal through the noise. She went from reluctant intern to global researcher shaping how we understand GPCR spatial signaling. Luck, Leadership & GPCR Signaling Michelle is clear: luck played a role. But so did choice. of Signaling laboratory, asking a deceptively simple question: where do GPCR signals happen—and how Spatial signaling isn’t just a technical detail. It’s a new language for drug discovery.
Other Pages (267)
- Posters | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
GPR110 modulates anxiety-like behaviors and memory function in mice potentially through neuronal and neuroimmune and to characterize ECR-mediated signal transduction at the molecular level." GPR110 modulates anxiety-like behaviors and memory function in mice potentially through neuronal and neuroimmune aimed to understand the effects of GPR110 on mouse behaviors in relation to neurodevelopmental and neuroimmune studying the role of GPR110 in neurotransmission and neuroimmune activity involved in learning and memory
- Targeting adenosine signaling for immuno-oncology
Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Targeting adenosine signaling for immuno-oncology Date & Time Friday, November 3rd / 4:35 PM Abstract "Adenosine (ADO) signaling through Potent inhibitors of ADO signaling are currently being tested in cancer patients, including in randomized I will present our recent work on adenosine-producing ectonucleotidases and adenosine signaling and discuss
- The Practical Assessment of Signaling Bias | Dr. GPCR Ecosystem
The Practical Assessment of Signaling Bias Dr.
Events (1)
- The Practical Assessment of Signaling BiasTickets: $306.48February 20, 2025 | 3:00 PM






